Prospective Evaluation of Patients With Pleural Effusion
Prospective Evaluation of the Aetiologies, Management and Clinical Outcomes in Patients With Pleural Effusion
1 other identifier
observational
1,000
1 country
2
Brief Summary
Having a pleural effusion is a common reason for being hospitalized, as it usually requires in-patient care for invasive diagnostic and therapeutic procedures. Specific subtypes of pleural effusion may warrant recurrent admissions, a longer hospital stay and consume more healthcare resources. Despite the recent advancement of pleural medicine, better research is increasingly desired to fill the gaps in establishing an early diagnosis and optimal management of pleural effusion from various causes. Local data on different aspects of pleural effusion is also lacking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2022
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 25, 2023
CompletedFirst Posted
Study publicly available on registry
March 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedAugust 31, 2023
August 1, 2023
3.6 years
February 25, 2023
August 29, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Aetiology of pleural effusion
spectrum of aetiology for pleural effusion
1 month
Secondary Outcomes (2)
Management of pleural effusion
1 month
Prognosis of pleural effusion
1 month
Study Arms (1)
Pleural effusion
All patients with pleural effusion who will undergo thoracentesis
Interventions
A type of pleural procedure that will yield pleural fluid for subsequent analysis
Eligibility Criteria
Patients who have pleural effusion and will undergo thoracentesis for pleural fluid sampling
You may qualify if:
- Patients hospitalized for pleural effusion.
- Pleural tapping will be performed for pleural fluid analysis.
- Aged 18 years old or above
You may not qualify if:
- \- Failed to obtain informed consent due to the patient's refusal or cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Chinese University of Hong Kong
Hong Kong, Hong Kong
Prince of Wales Hospital
Hong Kong, Hong Kong
Biospecimen
40mL pleural fluid will be collected during thoracentesis or pleural drain insertion, or from collecting bags. The research pleural fluid will be transferred on ice and stored at - 80oC until assay for subsequent approved studies. 6mL blood will be collected. The blood will be centrifuged, and the supernatant will be stored at - 80oC until assay for subsequent approved studies.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
David SC Hui, MD
Chinese University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Lecturer
Study Record Dates
First Submitted
February 25, 2023
First Posted
March 8, 2023
Study Start
September 1, 2022
Primary Completion
March 31, 2026
Study Completion
March 31, 2026
Last Updated
August 31, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share